Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.
Saved in:
| Title: | Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia. |
|---|---|
| Authors: | Romanová T; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Burša F; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Sklienka P; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Sagan J; Department of Infectious Diseases, University Hospital Ostrava, Ostrava, Czech Republic., Vaňková M; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic., Buršík D; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Bílená M; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Pulcer M; Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic., Burda M; Institute for Research and Applications of Fuzzy Modeling, CE IT4Innovations, University of Ostrava, Ostrava, Czech Republic., Máca J; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. |
| Source: | Therapeutics and clinical risk management [Ther Clin Risk Manag] 2024 Sep 10; Vol. 20, pp. 611-618. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101253281 Publication Model: eCollection Cited Medium: Print ISSN: 1176-6336 (Print) Linking ISSN: 11766336 NLM ISO Abbreviation: Ther Clin Risk Manag Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1176-6336 |
|---|---|
| DOI: | 10.2147/TCRM.S476187 |
